Welcome to our dedicated page for RXRA news (Ticker: RXRA), a resource for investors and traders seeking the latest updates and insights on RXRA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RXRA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RXRA's position in the market.
On March 16, 2021, RXR Acquisition Corp. announced the closing of an additional issuance of 4,500,000 units due to the underwriters' over-allotment option from its initial public offering. This added $45 million in gross proceeds, raising the total to $345 million. The units, which began trading on the Nasdaq under the ticker RXRA.U on March 4, 2021, comprise one share of Class A common stock and one-fifth of a redeemable warrant. The proceeds will be placed in trust, with Goldman Sachs and BofA Securities acting as joint-book running managers.
On March 8, 2021, RXR Acquisition Corp. announced the successful closing of its initial public offering (IPO), raising $300 million by selling 30 million units at $10.00 each. The units began trading on Nasdaq under the ticker symbol RXRA.U on March 4, 2021. Each unit consists of one share of Class A common stock and one-fifth of a redeemable warrant, with the whole warrant exercisable at $11.50 per share. The IPO's underwriters have a 45-day option to purchase up to 4.5 million additional units.
RXR Acquisition Corp. has announced the pricing of its upsized initial public offering (IPO) of 30 million units at $10.00 each. These units will trade on the Nasdaq under the symbol RXRA.U, starting March 4, 2021. Each unit includes one share of Class A common stock and one-fifth of a redeemable warrant, with each whole warrant exercisable at $11.50. The underwriters have a 45-day option to purchase an additional 4.5 million units. RXR aims to merge with businesses at the intersection of real estate and technology, known as PropTech.
FAQ
What is the market cap of RXRA (RXRA)?
